Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234429
Status:
COMPLETED
Last Update Posted:
2007-12-18
First Post:
2005-10-05
Brief Title:
A Phase 2 Study of Tomudex Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-05
First Submit QC Date:
October 5 2005
Study First Post Date:
2005-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-14
Last Update Post Date:
2007-12-18
Last Update Post Date Type:
ESTIMATED